This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Slit-trap

Sanofi

Drug Names(s): Slit-trap

Description: Slit-trap is being developed as a personalized therapy for certain types of liver cancer patients who have high levels of the protein slit, which nourishes the tumor and helps it to spread to other parts of the body. Slit-trap attempts to block this protein.

Deal Structure: Slit-trap was originally developed by the Shanghai Institutes of Biological Sciences.


Slit-trap News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug